Japanese researchers say a medicine designed to regrow teeth is moving toward human clinical trials. The breakthrough could shift dental care from treatment and replacement toward true regeneration, offering hope for people affected by decay and tooth loss. While early, the planned studies mark an important step from lab results to real-world testing in patients.
India’s drug regulator has accelerated pharma innovation by cutting approval timelines by more than half. Clinical trial approvals will now take about 120-135 days, while marketing authorisations are cleared in under 150 days. The reforms also remove certain pre-clinical approval requirements, aiming to strengthen ease of doing business and speed product delivery.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
